Pediatrix Upgraded to 'BB' Rating, Stronger Financial Position

S&P Global Ratings upgrades Pediatrix Medical Group to BB rating, reflecting lower debt and improved cash flow. Companys financial performance exceeds expectations, with adjusted debt dropping to 1.1 times earnings and free operating cash flow increasing by 25%. Despite a slight revenue dip due to office practice sales, Pediatrix projects growth of 5.3% in 2025 and 3.5% in 2026, driven by a successful revenue management model and strategic acquisitions.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.